Your browser doesn't support javascript.
loading
RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression.
Bozza, William P; Zhang, Yaqin; Hallett, Kory; Rivera Rosado, Leslie A; Zhang, Baolin.
Affiliation
  • Bozza WP; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
  • Zhang Y; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
  • Hallett K; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
  • Rivera Rosado LA; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
  • Zhang B; United States Public Health Service Commissioned Corps, Rockville, MD 20852, USA.
Oncotarget ; 6(32): 32723-36, 2015 Oct 20.
Article in En | MEDLINE | ID: mdl-26416248
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Rho GTP-Binding Proteins / Cyclooxygenase 2 / Rho Guanine Nucleotide Dissociation Inhibitor alpha Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Female / Humans Language: En Journal: Oncotarget Year: 2015 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Rho GTP-Binding Proteins / Cyclooxygenase 2 / Rho Guanine Nucleotide Dissociation Inhibitor alpha Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Female / Humans Language: En Journal: Oncotarget Year: 2015 Document type: Article Affiliation country: United States